HealthTree®

IMPROVING MYELOMA PATIENT OUTCOMES AND ACCELERATING A CURE

LIFE WITH MYELOMA

Patient Power: Diet Proves to Maintain Immune System for Myeloma Patients

Aug 13, 2018
If you take a stroll through any grocery store pharmacy, you'll see pill bottles that promise to be “Immune Boosters” or “Immunity Strengtheners.” Of course, multiple myeloma patients can be enticed because somehow, our im...
ADVERTISEMENT
CLINICAL TRIALS

Clinical Trial: New Inhibitor Tested for Patients With Relapsed or Refractory Multiple Myeloma

Aug 09, 2018
A phase I clinical trial is open testing AMG 176 in patients with relapsed or refractory multiple myeloma (as well as patients wi...
SIGN UP FOR OUR
NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.

GO

LIFE WITH MYELOMA
Aug 09, 2018
Cancer is a physically detrimental disease, but it’s ef...
MYELOMA CROWD RADIO

Full Show: Tips for Joining Popular Multiple Myeloma Clinical Trials with Brian McMahon of SparkCures

Aug 10, 2018
Brian McMahon SparkCures Interview Date: July 30, 2018[caption id="attachment_192...
MYELOMA CROWD RESEARCH INITIATIVE
$53,275 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
MYELOMA 101

Myeloma 101: What Is a FISH Test in Multiple Myeloma?

Jul 06, 2018
Myeloma genetics is an important piece of the myeloma puzzle. If we know what type of myeloma we have, we can see if there are patterns of treatments re...
MUSCLES FOR MYELOMA

Myeloma Crowd Cycling: Richard Hite, Myeloma Survivor

Jul 06, 2018
On July 14, 2018 Richard Hite, multiple myeloma cancer survivor, will be participating in the Cache Gran Fondo cycling event.  He will be riding along with other cancer survivors and team Myeloma Crowd Cycling to find a cure for multiple myeloma. He...
CLINICAL TRIALS

Clinical Trial: Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor for Advanced Multiple Myeloma

Jul 23, 2018
A new inhibitor is being combined with daratumumab for a Phase I multi-center, global study. R06870810 is a Bromodomain and Extra-Terminal (BET) Protein inhibitor, a new kind of drug that may inhibit the expression of genes that help myeloma cell...

FIND

Myeloma Financial Resource
FINANCIAL
RESOURCES
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Myeloma Specialist
MYELOMA
SPECIALISTS
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.